Skip to main content
. 2020 Dec 8;2020(12):MR000040. doi: 10.1002/14651858.MR000040.pub3

Comparison 1. Primary analyses.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Financial conflicts of interest 13   Risk Ratio (IV, Random, 95% CI) 1.26 [1.09, 1.44]
1.1.1 Clinical guidelines 4   Risk Ratio (IV, Random, 95% CI) 1.26 [0.93, 1.69]
1.1.2 Advisory committee reports 4   Risk Ratio (IV, Random, 95% CI) 1.20 [0.99, 1.45]
1.1.3 Opinion pieces 4   Risk Ratio (IV, Random, 95% CI) 2.62 [0.91, 7.55]
1.1.4 Narrative reviews 4   Risk Ratio (IV, Random, 95% CI) 1.20 [0.97, 1.49]